196 related articles for article (PubMed ID: 12056855)
1. Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection.
Lecour S; Smith RM; Woodward B; Opie LH; Rochette L; Sack MN
J Mol Cell Cardiol; 2002 May; 34(5):509-18. PubMed ID: 12056855
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase).
Lecour S; Suleman N; Deuchar GA; Somers S; Lacerda L; Huisamen B; Opie LH
Circulation; 2005 Dec; 112(25):3911-8. PubMed ID: 16344382
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
[TBL] [Abstract][Full Text] [Related]
4. TNF-alpha is required for late ischemic preconditioning but not for remote preconditioning of trauma.
Ren X; Wang Y; Jones WK
J Surg Res; 2004 Sep; 121(1):120-9. PubMed ID: 15313385
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning.
Dawn B; Guo Y; Rezazadeh A; Wang OL; Stein AB; Hunt G; Varma J; Xuan YT; Wu WJ; Tan W; Zhu X; Bolli R
J Mol Cell Cardiol; 2004 Jul; 37(1):51-61. PubMed ID: 15242735
[TBL] [Abstract][Full Text] [Related]
6. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.
Das B; Sarkar C
J Cardiovasc Pharmacol; 2006 Feb; 47(2):277-86. PubMed ID: 16495767
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotection of interleukin-2 is mediated via kappa-opioid receptors.
Cao CM; Xia Q; Tu J; Chen M; Wu S; Wong TM
J Pharmacol Exp Ther; 2004 May; 309(2):560-7. PubMed ID: 14747612
[TBL] [Abstract][Full Text] [Related]
8. Free radicals trigger TNF alpha-induced cardioprotection.
Lecour S; Rochette L; Opie L
Cardiovasc Res; 2005 Jan; 65(1):239-43. PubMed ID: 15621052
[TBL] [Abstract][Full Text] [Related]
9. The mitochondrial permeability transition pore and the Ca2+-activated K+ channel contribute to the cardioprotection conferred by tumor necrosis factor-alpha.
Gao Q; Zhang SZ; Cao CM; Bruce IC; Xia Q
Cytokine; 2005 Dec; 32(5):199-205. PubMed ID: 16260145
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotection via activation of protein kinase C-delta depends on modulation of the reverse mode of the Na+/Ca2+ exchanger.
Bouwman RA; Salic K; Padding FG; Eringa EC; van Beek-Harmsen BJ; Matsuda T; Baba A; Musters RJ; Paulus WJ; de Lange JJ; Boer C
Circulation; 2006 Jul; 114(1 Suppl):I226-32. PubMed ID: 16820577
[TBL] [Abstract][Full Text] [Related]
11. Ceramide-induced preconditioning involves reactive oxygen species.
Lecour S; Owira P; Opie LH
Life Sci; 2006 Mar; 78(15):1702-6. PubMed ID: 16293265
[TBL] [Abstract][Full Text] [Related]
12. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-alpha production. Potential ultimate effector mechanism of preconditioning.
Meldrum DR; Dinarello CA; Shames BD; Cleveland JC; Cain BS; Banerjee A; Meng X; Harken AH
Circulation; 1998 Nov; 98(19 Suppl):II214-8; discussion II218-9. PubMed ID: 9852905
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological preconditioning with monophosphoryl lipid A improves post ischemic diastolic function and modifies TNF-alpha synthesis.
Sharony R; Frolkis I; Froylich D; Wildhirt SM; Shapira I; Reichart B; Nesher N; Uretzky G
Eur J Cardiothorac Surg; 2005 Mar; 27(3):501-7. PubMed ID: 15740963
[TBL] [Abstract][Full Text] [Related]
14. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
Sivarajah A; McDonald MC; Thiemermann C
Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
[TBL] [Abstract][Full Text] [Related]
15. Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition.
Giricz Z; Lalu MM; Csonka C; Bencsik P; Schulz R; Ferdinandy P
J Pharmacol Exp Ther; 2006 Jan; 316(1):154-61. PubMed ID: 16166272
[TBL] [Abstract][Full Text] [Related]
16. Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning.
Teoh N; Leclercq I; Pena AD; Farrell G
Hepatology; 2003 Jan; 37(1):118-28. PubMed ID: 12500196
[TBL] [Abstract][Full Text] [Related]
17. [Sphingolipid signaling: a potential pathway for TNF-alpha induced preconditioning].
Lecour S; Sack MN; Opie LH
Ann Cardiol Angeiol (Paris); 2003 Dec; 52(6):363-9. PubMed ID: 14752919
[TBL] [Abstract][Full Text] [Related]
18. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
19. [Cardioprotection of recombinant human erythropoietin pretreatment on ischemia-reperfused hearts and mechanism thereof: experiment with rats].
Liu XM; Jia Z; Zhou ZQ; Xu JG
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2463-7. PubMed ID: 18067805
[TBL] [Abstract][Full Text] [Related]
20. Role of ceramide in ischemic preconditioning.
Cui J; Engelman RM; Maulik N; Das DK
J Am Coll Surg; 2004 May; 198(5):770-7. PubMed ID: 15110811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
